A Multi-Component Meningococcal Serogroup B Vaccine (4CMenB): The Clinical Development Program
Open Access
- 12 December 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs
- Vol. 74 (1), 15-30
- https://doi.org/10.1007/s40265-013-0155-7
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Bactericidal Antibody Persistence 2 Years After Immunization With 2 Investigational Serogroup B Meningococcal Vaccines at 6, 8 and 12 Months and Immunogenicity of Preschool Booster DosesThe Pediatric Infectious Disease Journal, 2013
- Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster doseCMAJ : Canadian Medical Association Journal, 2013
- Interlaboratory Standardization of the Sandwich Enzyme-Linked Immunosorbent Assay Designed for MATS, a Rapid, Reproducible Method for Estimating the Strain Coverage of Investigational VaccinesClinical and Vaccine Immunology, 2012
- Immunogenicity and Safety of a Multicomponent Meningococcal Serogroup B Vaccine and a Quadrivalent Meningococcal CRM 197 Conjugate Vaccine against Serogroups A, C, W-135, and Y in Adults Who Are at Increased Risk for Occupational Exposure to Meningococcal IsolatesClinical and Vaccine Immunology, 2011
- Extensive Genomic Variation within Clonal Complexes of Neisseria meningitidisGenome Biology and Evolution, 2011
- Immunogenicity of Two Investigational Serogroup B Meningococcal Vaccines in the First Year of LifeThe Pediatric Infectious Disease Journal, 2010
- Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccinesProceedings of the National Academy of Sciences of the United States of America, 2010
- The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiologyBMC Infectious Diseases, 2010
- Review of Meningococcal Group B VaccinesClinical Infectious Diseases, 2010
- A universal vaccine for serogroup B meningococcusProceedings of the National Academy of Sciences of the United States of America, 2006